Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity. | Bioorg Chem | 2024 | 38237393 | PubTator, text mining | PubMed |
| Late-Stage Functionalization of Living Organisms: Rethinking Selectivity in Biology. | Chem Rev | 2024 | 38231473 | PubTator, text mining | PubMed |
| Future of low back pain: unravelling IVD components and MSCs' potential. | Cell Regen | 2024 | 38227139 | PubTator, text mining | PubMed |
| Morphological, phytochemical and genetic characterization of Centella asiatica accessions collected throughout Vietnam and Laos. | Saudi J Biol Sci | 2024 | 38173443 | PubTator, text mining | PubMed |
| Multifunctional nanoparticle-mediated combining therapy for human diseases. | Signal Transduct Target Ther | 2024 | 38161204 | PubTator, text mining | PubMed |
| Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). | Int J Oncol | 2024 | 38038050 | PubTator, text mining | PubMed |
| Novel sulfonamide-phosphonate conjugates as carbonic anhydrase isozymes inhibitors. | Drug Dev Res | 2024 | 37997034 | PubTator, text mining | PubMed |
| Green Synthesis of a Novel Phytoalexin Derivative: In Silico Profiling, Apoptotic Induction, and Antiproliferative Activity against MCF-7 cells - From Vineyards to Potent Anticancer Drug Molecule. | Anticancer Agents Med Chem | 2024 | 37936468 | PubTator, text mining | PubMed |
| Radiation-Related Thyroid Cancer. | Endocr Rev | 2024 | 37450579 | PubTator, text mining | PubMed |
| Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment. | Pharmaceutics | 2023 | 38258070 | PubTator, text mining | PubMed |
| Cartilaginous endplates: A comprehensive review on a neglected structure in intervertebral disc research. | JOR Spine | 2023 | 38156054 | PubTator, text mining | PubMed |
| Defining the Cell Surface Cysteinome Using Two-Step Enrichment Proteomics. | JACS Au | 2023 | 38155636 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential. | Pharmaceuticals (Basel) | 2023 | 38139858 | PubTator, text mining | PubMed |
| Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice. | Int J Mol Sci | 2023 | 38139457 | PubTator, text mining | PubMed |
| Macrophages and platelets in liver fibrosis and hepatocellular carcinoma. | Front Immunol | 2023 | 38116017 | PubTator, text mining | PubMed |
| Co-vulnerabilities of inhibiting carbonic anhydrase IX in ferroptosis-mediated tumor cell death. | Front Mol Biosci | 2023 | 38099193 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review. | Cancer Med | 2023 | 38098217 | PubTator, text mining | PubMed |
| Ureidobenzenesulfonamides as Selective Carbonic Anhydrase I, IX, and XII Inhibitors. | Molecules | 2023 | 38067512 | PubTator, text mining | PubMed |
| Formation of morpholine-acetamide derivatives as potent anti-tumor drug candidates: Pharmacological evaluation and molecular docking studies. | Heliyon | 2023 | 38053851 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=7